Maverick* Research: Cognitive Enhancement Drugs Are Changing Your Business


Published: 21 September 2017 ID: G00340162

Analyst(s):

Not a Gartner Client?

Want more research like this?
Learn the benefits of becoming a Gartner client.

contact us online

Summary

Competitive and social pressures are pushing knowledge workers, including IT professionals, to experiment with cognitive enhancement drugs. CIOs in the vanguard will be the first impacted and must take an early leadership position. (Maverick research exposes unconventional thinking and advice.)

Table of Contents

  • *Maverick Research
  • Analysis
    • Do "Smart Drugs" Make You Smarter?
      • Scenarios for CED Adoption
    • Advantages of CEDs in the Enterprise
      • Synthesizing New Insights
      • Supporting Workers at the Lower End of the Cognitive Spectrum
    • The Ethics of Cognitive Enhancement
      • Legal Status of CEDs
      • Stacking Side Effects
      • Overestimating Cognitive Abilities
      • Social Coercion
      • Impact on Authenticity
    • Recommendations
  • Gartner Recommended Reading
© 2017 Gartner, Inc. and/or its Affiliates. All Rights Reserved. Reproduction and distribution of this publication in any form without prior written permission is forbidden. The information contained herein has been obtained from sources believed to be reliable. Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information. Although Gartners research may discuss legal issues related to the information technology business, Gartner does not provide legal advice or services and its research should not be construed or used as such. Gartner shall have no liability for errors, omissions or inadequacies in the information contained herein or for interpretations thereof. The opinions expressed herein are subject to change without notice.

Free Research

Discover what 12,000 CIOs and Senior IT leaders already know.

Free Access

Why Gartner

Gartner delivers the technology-related insight you need to make the right decisions, every day.

Find out more